跳至主要内容
临床试验/EUCTR2010-018581-23-IT
EUCTR2010-018581-23-IT进行中(未招募)不适用

CONSERVATIVE MANAGEMENT OF ENDOMETRIAL CANCER AND ATYPICAL HYPERPLASIA - ND

ISTITUTO NAZIONALE PER LO STUDIO E LA CURA DEI TUMORI - FONDAZIONE G. PASCALE0 个研究点开始时间: 2010年12月22日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
Female

入选标准

  • ? age ≤ 40 years
  • ? P.S. WHO scale 0-1
  • ? diagnosis of well differentiated stage IA (intramucous) EEC or EAI
  • ? ER/PR positive
  • ? normal serum levels of CA125 (< 35 IU/ml)
  • ? informed consent to conservative management
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • ? multifocal endometrial cancer
  • ? concomitant cancers except for properly treated cutaneous basocellular carcinoma and in situ cervical carcinoma.
  • ? HPNCC-Lynch II syndrome
  • ? controindications for LNG-IUD insertion
  • ? acute and chronic liver diseases

研究者

发起方
ISTITUTO NAZIONALE PER LO STUDIO E LA CURA DEI TUMORI - FONDAZIONE G. PASCALE

相似试验